USPTO serial 79366009
SYNBÆCTIVE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 2, 2024
- Examiner
- LUEKEN, ABIGAIL JOSEPHINE
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with SYNBÆCTIVE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Michelle E. Tochtrop
Michelle E. Tochtrop Chrisman Gallo Tochtrop LLC6509 Brecksville Road, #31550CLEVELAND, OH 44131-4854United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Preparations of microorganisms not for medical or veterinary use; bacteriological preparations not for medical or veterinary use; cultures of microorganisms for industrial use; bacteriological preparations for industrial use; milk enzymes for industrial use; cultures of microorganisms for food industry; bacteriological preparations for food industry; lactic ferments for food industry; fermentation extracts for industrial use; lactic ferments for chemical use; raw materials in the nature of chemicals, chemical products, chemical additives and chemical compounds for industrial use in the formulation and preparation of pharmaceuticals, parapharmaceuticals, nutraceuticals, nutritional, medical foods and dietary substances, foods for babies and dietary substances for medical use, functional foods and nutraceuticals for medical use, dietary supplements for medical use, food supplements for humans; raw materials in the nature of chemicals, cultures of microorganisms, bacteriologic preparations, probiotic bacterial preparations, milk enzymes, all the above products used as ingredients for the production of pharmaceuticals, medical and veterinary preparations, hygienic products for medical purposes, foods and dietary substances for medical or veterinary use, foods for babies, food supplements for humans and animals, nutritional additives for medical use, food supplements, nutraceutical foods used as supplements, preparations for vaginal douches for medical use, disinfectant products, detergents for medical use, cleaning products for personal use, dermatological products for medical use, dermatological products for non-medical use; bacteriological cultures to be added to food, milk and dairy products, including fermented milk products, other than for medical and veterinary use; cultures of microorganisms not for medical purposes; bacterial substances for industrial use; bacteria used in food production; bacterial preparations for food industry; additive bacterial cultures for food products; bacterial preparations and cultures not for medical use; milk enzymes and bacterial preparations used in food production; antioxidants, fatty acids, proteins, enzymes, liposomes, cultures of microorganisms, bacteria to produce lactic acid, and probiotic compounds all for use in the manufacture of pharmaceuticals, dietary compounds for human use, food for babies, nutritional supplements, dietary supplements, dietary supplements for medical use, and dietary foods; probiotic bacteria for the food industry; probiotic bacteria preparations not for medical use; industrial chemicals; chemicals intended for food preservation; raw chemical materials for the formulation of foods, supplements, dietetic foods, dietetic foods and supplements not for medical purposes, dietetic foods for babies, dietetic food preparations for medical use; microorganisms, bacteria, probiotic bacteria, yeasts, fungi, and molds for industrial use, microorganisms, bacteria, probiotic bacteria, yeasts, fungi, and molds not for medical purposes, cultures of microorganisms not for medical purposes; cultures of bacteria not for medical purposes; preparations of cultures of microorganisms not for medical purposes; preparations of cultures of bacteria not for medical purposes; bacterial substances for industrial use; microorganisms and bacteria used in the production of food and supplements; probiotic bacteria for food and supplement industry; bacterial preparations for food and supplement industry; additive bacterial cultures for food and supplement products; bacterial preparations and bacterial cultures not for medical use; milk enzymes and bacterial preparations used for food and supplement production; antioxidants, anti-inflammatories, organic and inorganic acids, fatty acids, lipoic acid, glutathione, red rice, vitamins, esters, minerals, trace elements, proteins, amino acids, enzymes, liposomes, cultures of microorganisms and probiotic bacteria, bacteria to produce lactic acid and probiotic compounds all for use in the manufacture of pharmaceuticals, veterinary products, human dietary compounds, food for babies, nutritional supplements, dietary supplements, medical food supplements and dietary foods; probiotic bacterial preparations not for medical use; fermentation products, enzymes and chemical additives for industrial purposes; fermentation extracts for industrial use; microorganism cultures used in forage fermentation; soil fertilizers | ACTIVE | — |
| 005 | Medical and veterinary products and preparations for use in the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, diabetes, gastro-intestinal conditions, uro-genital disorders, infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity, cognitive disorders, conditions of the skin and tissue, erectile dysfunction, bone diseases or disorders, allergies, metabolic disorders, endocrine diseases, musculoskeletal diseases or disorders, cardiovascular diseases or disorders, cardiopulmonary diseases or disorders, genitourinary diseases or disorders, sexual dysfunction, oncological conditions, hepatological conditions, respiratory diseases or disorders, neurological diseases or disorders, gastrointestinal diseases or disorders, psychiatric conditions, allergic rhinitis, viral infections and diseases, gastro-intestinal diseases, halitosis, all for use in humans and animals; foods and dietary substances for medical or veterinary use; foods for babies; food supplements for humans and animals; dietary supplements for humans and animals; cultures of microorganisms for medical, pharmaceutical or veterinary use; preparations of microorganisms for pharmaceutical, medical or veterinary use; bacteriological preparations for medical, veterinary and pharmaceutical use; milk enzymes for medical, veterinary and pharmaceutical use; cultures of microorganisms for dietary supplements; dietary supplements; nutraceuticals used as dietary supplements; dietary supplements and foods containing microorganisms, especially bacteria, lactic acid bacteria, bifidobacteria, spores, yeasts, fungi or molds; pharmaceutical and parapharmaceutical products and preparations for use in the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, diabetes, gastro-intestinal conditions, uro-genital disorders, infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity, cognitive disorders, conditions of the skin and tissue, erectile dysfunction, bone diseases or disorders, allergies, metabolic disorders, endocrine diseases, musculoskeletal diseases or disorders, cardiovascular diseases or disorders, cardiopulmonary diseases or disorders, genitourinary diseases or disorders, sexual dysfunction, oncological conditions, hepatological conditions, respiratory diseases or disorders, neurological diseases or disorders, gastrointestinal diseases or disorders, psychiatric conditions, allergic rhinitis, viral infections and diseases, gastro-intestinal diseases, halitosis; gynecological, urological, gastroenterological, immunological, cardio-vascular, dermatological, oral hygiene and osteo-articular products and preparations and pharmaceutical and parapharmaceutical preparations; sanitary, hygienic, nutraceutical, symbiotic, nutritional, probiotic, prebiotic and homeopathic products, preparations and compounds for medical purposes; veterinary products, preparations and veterinary compounds for use in the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, diabetes, gastro-intestinal conditions, uro-genital disorders, infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity, cognitive disorders, conditions of the skin and tissue, erectile dysfunction, bone diseases or disorders, allergies, metabolic disorders, endocrine diseases, musculoskeletal diseases or disorders, cardiovascular diseases or disorders, cardiopulmonary diseases or disorders, genitourinary diseases or disorders, sexual dysfunction, oncological conditions, hepatological conditions, respiratory diseases or disorders, neurological diseases or disorders, gastrointestinal diseases or disorders, psychiatric conditions, allergic rhinitis, viral infections and diseases, gastro-intestinal diseases, halitosis, all for use in animals; dietary food supplements; dietary supplements; nutritional supplements; dietary substances in the nature of supplements; dietary, nutritional, mineral, and food supplements for medical and not for medical non-medical purposes, namely, nutraceutical, vitamin, antioxidant, saprophytic bacterial flora and homeopathic supplements, substances and preparations; enzyme dietary supplements and protein dietary supplements; dietary supplements for people with special dietary needs; herbal dietary supplements for people with special dietary needs; dietary supplement drinks; dietary foods and substances in the nature of infant formula and supplements for newborn babies; dietary food supplements not for medical purposes; cultures of microorganisms for medical purposes; preparations of microorganisms for medical purposes; dietary supplements for animals; protein supplements for animals; disinfectants; pre-moistened medicated tissues; sanitary napkins; disinfectant wipes; sanitising wipes; probiotic bacterial preparations for medical or veterinary use. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 10, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 3, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 7, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 7, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 7, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 7, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| May 7, 2025 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Oct 2, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 2, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jul 2, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 16, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 16, 2024 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Apr 16, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 10, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 10, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 10, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 27, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 27, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 27, 2024 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Mar 12, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 12, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 12, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 12, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 12, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 14, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 14, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 14, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 13, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 18, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 18, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 20, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 19, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 18, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 1, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 28, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 23, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |